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Background
All current anti-HIV1 therapies target the viral proteins
or RNA; however targeting HIV1 at the transcriptional
level of the integrated provirus has been less explored.
In India, AIDS is commonly caused by HIV-1C com-
pared to HIV-1B in developed countries. HIV1-5’LTR
acts as a promoter and shows sequence variation among
different clades. Transcriptional gene silencing (TGS) is
a method wherein dsRNA targeting the promoter/
enhancer of a gene are used to down regulate its
expression.
Methods
We used SiHa cell line stably expressing a bi-cistronic
reporter system (5’LTR-SEAP-IRES-EGFP), in which
secreted alkaline phosphatase (SEAP) and enhanced
green fluorescent protein (EGFP) are expressed under
5’LTR of HIV-1B/C. The cell line was transfected with
different dsRNAs (S1-S6) targeting the core promoter/
enhancer of HIV-1C LTR to induce TGS. Screening for
decreased transcription was done using real-time PCR
(mRNA expression of SEAP and EGFP), fluorescence
microscopy (EGFP) and flow cytometry (EGFP).
Results
After single or multiple (thrice) transfection of dsRNAs,
we identified one dsRNA (S4) which showed consistent
and significant down regulation of both SEAP (44% &
68% respectively) and EGFP (40% & 65%) (p<0.001 in
both cases) mRNA levels. This reporter down regulation
was also confirmed by studying EGFP expression using
fluorescence microscopy and flowcytometry which also
showed a significant fall after S4 transfection.
Conclusion
TGS usually involves epigenetic modifications like DNA
methylation/histone methylation at the targeted region
and induces long term suppression of gene expression.
So targeting of the HIV-1C LTR by dsRNA can be used
as a therapeutic modality in the future.
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